CARD || Clinical News

Liraglutide gains clout as weight loss agent for overweight, nondiabetic patients

Posted on: 18/05/2014 - 13:25

LAS VEGAS – The antidiabetic drug liraglutide (Victoza) promotes weight loss in overweight and obese individuals who do not have diabetes, according to results from a randomized trial reported on May...

Field of Interest: Endocrinology

Type: News Item

Testosterone therapy may not be associated with CV risk

Posted on: 17/05/2014 - 17:13

LAS VEGAS – Analysis of data from a low testosterone therapy company showed that...

Field of Interest: Endocrinology

Type: News Item

Evolocumab lowers LDL-C with no effect on glucose metabolism

Posted on: 17/05/2014 - 15:00

LAS VEGAS – Evolocumab, an investigational antibody that inhibits PCSK9, reduces levels of low-density lipoprotein cholesterol in hypercholesterolemic patients who have dysglycemia or metabolic...

Field of Interest: Endocrinology

Type: News Item

FDA rejects serelaxin for acute heart failure

Posted on: 16/05/2014 - 21:45

The Food and Drug Administration has decided that more evidence of serelaxin’s efficacy as a treatment for acute heart failure is needed before the drug can be approved in the United States, Novartis...

Field of Interest: Cardiology

Type: News Item

Sex, ancestry play roles in diabetes rates in Hispanics

Posted on: 16/05/2014 - 17:40

LAS VEGAS – Hispanic adults have high prevalences of diabetes and related disorders overall, the largest ongoing U.S. health study of this population showed, but there are noteworthy differences by...

Field of Interest: Endocrinology

Type: News Item

Defibrillation testing at ICD placement did not reduce failed shocks or arrhythmic deaths

Posted on: 16/05/2014 - 16:40

SAN FRANCISCO – Defibrillation testing at the time of implantable cardioverter defibrillator implantation is safe, but it does not improve clinical shock efficacy or prevent death, results from a...

Field of Interest: Cardiology

Type: News Item

Remote monitoring of devices boosted survival

Posted on: 16/05/2014 - 16:35

SAN FRANCISCO – Patients with implantable pacemakers and defibrillators who engage in remote monitoring at more than 75% adherence rates have a 2.4-fold higher rate of survival than those who do not...

Field of Interest: Cardiology

Type: News Item

Bariatric surgery sliced asthma inhaler use

Posted on: 15/05/2014 - 22:35

MADRID – Morbidly obese asthmatics may require less inhaler therapy after bariatric surgery, a retrospective chart review and longitudinal cohort study suggests. Among patients who used any form of...

Field of Interest: Endocrinology

Type: News Item

20-study analysis finds no MACE increase with saxagliptin

Posted on: 15/05/2014 - 17:45

Treatment with saxagliptin was not associated with an increased risk of major adverse cardiovascular events or heart failure in a pooled analysis of 20 studies of patients with type 2 diabetes.<br...

Field of Interest: Endocrinology

Type: News Item

Empagliflozin improves glycemia, blood pressure in type 2 diabetes study

Posted on: 15/05/2014 - 17:45

Treatment with empagliflozin, an investigational sodium-glucose cotransporter 2 (SGLT2) inhibitor, was associated with benefits for blood pressure as well as glycemic control in a 3-month study of...

Field of Interest: Endocrinology

Type: News Item

Liraglutide gains clout as weight loss agent for overweight, nondiabetic patients

Testosterone therapy may not be associated with CV risk

Evolocumab lowers LDL-C with no effect on glucose metabolism

FDA rejects serelaxin for acute heart failure

Sex, ancestry play roles in diabetes rates in Hispanics

Defibrillation testing at ICD placement did not reduce failed shocks or arrhythmic deaths

Remote monitoring of devices boosted survival

Bariatric surgery sliced asthma inhaler use

20-study analysis finds no MACE increase with saxagliptin

Empagliflozin improves glycemia, blood pressure in type 2 diabetes study

Newsletters

Latest Newsletters

You are here

CARD || Clinical News

Newsletters

Latest Newsletters